Fundraising FoxLophora
2 known investors
Find your way into Lophora
Sign up to see every warm intro you have to Lophora
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lophora team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lophora is a clinical-stage CNS therapeutics company developing selective 5-HT2A receptor agonists intended to induce neuroplasticity for mood and anxiety disorders. Its lead compound LPH-5 has completed a Phase I trial as a potential at-home treatment for depressive disorders, with additional pre-clinical candidates in its pipeline.
Investors · 2
Frequently asked questions
- What does Lophora do?
- Lophora is a clinical-stage CNS therapeutics company developing selective 5-HT2A receptor agonists intended to induce neuroplasticity for mood and anxiety disorders. Its lead compound LPH-5 has completed a Phase I trial as a potential at-home treatment for depressive disorders, with additional pre-clinical candidates in its pipeline.
- Who are Lophora's investors?
- Lophora's investors include Innovation Fund Denmark, Mystic Ventures.